##### ยง 513.200 Payment process and beneficiary cost-sharing. #####

(a) *General.* For purposes of the MFN Model, the allowed MFN Drug Payment Amount does not exceed the billed amount on the claim for the MFN Model drug.

(b) *Model-specific billing instructions.* MFN participants submit claims for MFN Model drugs to the applicable MAC in the form and manner specified by CMS in model-specific billing instructions.

(c) *Beneficiary cost-sharing.* Beneficiary coinsurance does not apply to the portion of the allowed payment amount for an MFN Model drug that is determined under ยง 513.220.